MEGAN MCCORMACK: Open Payments
NPI 1497153308 · LIBERTY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,367 in 134 payments from 14 companies in 2025. Trend: 2023 $1,074 · 2024 $1,739 · 2025 $2,367
Food & beverage: $2,367
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $683 |
| Otsuka America Pharmaceutical, Inc. | 24 | $376 |
| Teva Pharmaceuticals USA, Inc. | 14 | $186 |
| Indivior Inc. | 11 | $169 |
| Braeburn Inc. | 8 | $148 |
| Neurocrine BioSciences, Inc. | 6 | $141 |
| Alkermes, Inc. | 6 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $103 |
| Axsome Therapeutics, Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, SUBLOCADE, AUSTEDO XR, BRIXADI, INGREZZA, REXULTI, CAPLYTA.
Industry payments across NY — which companies pay providers there.
